Research Analysts’ Recent Ratings Changes for BWX Technologies (BWXT)

Several brokerages have updated their recommendations and price targets on shares of BWX Technologies (NYSE: BWXT) in the last few weeks:

• 8/14/2026 – BWX Technologies had its price target lowered by Truist Financial Corporation from $212.00 to $202.00. They now have a “hold” rating on the stock.
• 8/12/2026 – BWX Technologies was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 8/8/2026 – BWX Technologies was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/4/2026 – BWX Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $235.00 price target on the stock.
• 7/29/2026 – BWX Technologies was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 7/27/2026 – BWX Technologies is now covered by JPMorgan Chase & Co.. They set an “overweight” rating and a $230.00 price target on the stock.

BWX Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, August 18th. BWX Technologies’s dividend payout ratio is presently 27.98%.

Insider Buying and Selling

In related news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $172.50, for a total value of $1,725,000.00. Following the transaction, the chief executive officer owned 192,491 shares in the company, valued at approximately $33,204,697.50. This trade represents a 4.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.